VANCOUVER, Aug. 2, 2018 /CNW/ – Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) (“Pivot” or the “Company”) is pleased to announce that it has entered into a Definitive Co-marketing and Distribution Agreement (“the Agreement”) with S.T.U. GmbH (“S.T.U.”), a Switzerland-based company that manufactures and markets “Hemplix™” brand CBD oils. Under the terms of the... Read more
SpeakEasy Announces Plans for Massive Outdoor Production
August 1, 2018
Ryan Allway August 1st, 2018 News, Press Releases SpeakEasy Cannabis Club Ltd. (CSE : EASY) (Frankfurt : 39H), a late stage ACMPR applicant, today announces its plans to begin work on its first 60 acre outdoor plantation and process facility in Rock Creek BC for the spring of 2019. If we... Read more
Robin Lefferts August 1st, 2018 Exclusive, Feature Stories, News There are advantages in growing cannabis in hybridized, high tech greenhouses that combine the best of the indoor environment with the best of the sun-grown environment. There are also reasons to think that growing and selling certified organic cannabis... Read more
Wallace Grafton August 1st, 2018 Exclusive, News, Top News Pure Global Cannabis Inc. (TSXV:PURE) (OTC: PRCNF) is launching Canada’s first multi-ponic cannabis farm – a patent-pending system that is expected to produce several fold greater yields over traditional methods while reducing cost and eliminating pesticide and herbicide use. ... Read more
Significant Bioavailability Results in Human Clinical Trial using Lexaria’s DehydraTECH™ Powered TurboCBD™ Capsules
August 1, 2018
Ryan Allway August 1st, 2018 News, Press Releases, Top News Kelowna, British Columbia – August 1, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, is pleased to report significant bioavailability results from its randomized, placebo-controlled, double-blind European human... Read more
KITCHENER, Ontario, July 31, 2018 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA), a leading licensed cannabis producer, is pleased to announce that on July 23, 2018, it entered into a consulting agreement (the “Agreement”) with leading investor relations firm, First Canadian... Read more
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) announced today the New York Department of Health has approved MedMen’s request to manufacture and sell cannabis-infused lotions and topical pain-alleviating sprays for qualified medical marijuana patients. MedMen’s four stores in New York currently offer vaporizer pens, tinctures... Read more
Music Executive Jay Brown Joins MedMen’s Board
July 31, 2018
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) is pleased to announce that RocNation Co-founder and CEO Jay Brown has joined its Board of Directors. This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20180731005363/en/ Jay Brown Joins MedMen’s Board (Photo: Business Wire) A seasoned entrepreneur and... Read more
Ryan Allway July 31st, 2018 Exclusive, News, Top News The U.S. cannabis industry is expected to reach more than $75 billion in size by 2030, according to Cowen & Co., driven by the legalization of medical and adult-use cannabis across a growing number of states. Not surprisingly, these... Read more
MedMen Issues Subordinate Voting Shares in Satisfaction of Acquisition Post-Closing Payment
July 27, 2018
MedMen Enterprises Inc. (“MedMen” or the “The Company”), (CSE: MMEN) (OTCQB: MMNFF) a leading cultivator, producer and retailer of state-sanctioned cannabis, announced today that it has issued 602,500 Class B subordinate voting shares at a deemed price of C$4.64 per share as satisfaction for a post-closing payment related to... Read more
